References
- Provan, D. and Newland, A. (2002) "Fifty years of idiopathic thrombocytopenic purpura (ITP): management of refractory ITP in adults. Review", Br. J. Haematol. 118, 933–944.
- George, J., Woolf, S., Raskob, G., Wasser, J., Aledort, L., Ballem, P., Blanchette, V, Bussel, J., Cines, D., Kelton, J., Lichtin, A., McMilan, R., Okerbloom, J., Regan, D. and Warner, I. (1996) "Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology", Blood 88, 3–40.
- Zaja, E, Iacoma, I., Masolini, P, Russo, D., Sperotto, A., Prosdocimo, S., Patriarca, E, Vita, S., Regazzi, M., Baccarani, M. and Fanin, R. (2002) "B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia", Haematologica 87, 189–195.
- Berentsen, S., Tjonnfjord, G., Brudevold, R., Gjertsen, B., Langholm, R., Lokkevik, E., Sobro, J.H. and Ulvestad, E. (2001) "Favourable response to therapy with the anti-CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease", Br. J. Haematol. 115, 79–83.
- Hassan, G. (2002) "Successful treatment of pure red cell aplasia with rituximab in patients with chronic lymphocytic leukemia", Blood 99, 1092–1094.
- Reff, M.E., Carner, K., Chambers, K.S., Chirm, C., Leonard, J. and Raab, R. (1994) "Depletion of B cell in vivo by a chimeric mouse human monoclonal antibody to CD20", Blood 83, 435–445.
- Stasi, R., Pagano, A., Stipa, E. and Amadori, S. (2001) "Rituximab chimeric anti-CD20 monoclonal antibody treat-ment for adults with chronic idiopathic thrombocytopenic purpura", Blood 98, 952–957.
- Delgado, J., Bustos, J., Jimenez-Yuste, V. and Hernandez-Navarro, E (2002) "Anti-CD20 monoclonal antibody therapy in refractory immune thrombocytopenic purpura", Haemato-logica 87, 215–216.
- Stasi, R., Stipa, E., Forte, V, Meo, P. and Amadori, S. (2002) "Variable patterns of response to rituximab treatment in adults with chronic idiopathic thrombocytopenic purpura", Blood 99, 3872–3873.
- Heelan, B., Tormey, V, Amlot, P., Payne, E., Mehta, A. and Webster, D. (2002) "Effect of anti-CD20 (rituximab) on resistant thrombocytopenia in autoimmune lympho-proliferative syndrome", Br. J. Haematol. 118, 1078–1081.